Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,131 | -14,927 | -11,187 | -7,620 | -2,286 |
| Depreciation Amortization | 360 | 1,386 | 1,035 | 684 | 345 |
| Accounts receivable | 3,823 | -1,194 | -5,692 | 76 | -2,314 |
| Other Working Capital | -702 | -12,012 | -12,315 | -5,988 | -4,611 |
| Other Operating Activity | -3,348 | 1,747 | 5,770 | -337 | 3,037 |
| Operating Cash Flow | $-2,998 | $-25,000 | $-22,389 | $-13,185 | $-5,829 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,000 | 11,000 | 6,000 | N/A | N/A |
| PPE Investments | -248 | -628 | -415 | -357 | -229 |
| Purchase Of Investment | N/A | -16,000 | -16,000 | -16,000 | -16,000 |
| Other Investing Activity | -20 | 593 | 427 | 457 | -28 |
| Investing Cash Flow | $4,732 | $-5,035 | $-9,988 | $-15,900 | $-16,257 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,233 | 8,238 | 4,163 | 2,643 | N/A |
| Financing Cash Flow | $14,233 | $8,238 | $4,163 | $2,643 | $N/A |
| Exchange Rate Effect | -42 | -77 | -51 | -51 | -11 |
| Beginning Cash Position | 17,111 | 38,985 | 38,985 | 38,985 | 38,985 |
| End Cash Position | 33,036 | 17,111 | 10,720 | 12,492 | 16,888 |
| Net Cash Flow | $15,925 | $-21,874 | $-28,265 | $-26,493 | $-22,097 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,998 | -25,000 | -22,389 | -13,185 | -5,829 |
| Capital Expenditure | -248 | -628 | -415 | -357 | -229 |
| Free Cash Flow | -3,246 | -25,628 | -22,804 | -13,542 | -6,058 |